Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis

Journal of Gastroenterology

Volumn 35, Issue 3, 2000, Pages 214-220

  Toda, Kyoko ^a   Kumagai, Naoki ^a   Tsuchimoto, Kanji ^a   Inagaki, Hiroyuki ^a   Suzuki, Tatsuo ^a   Oishi, Tazuko ^b   Atsukawa, Kazuhiro ^b   Saito, Hidetsugu ^b   Morizane, Toshio ^b   Hibi, Toshifumi ^b   Ishii, Hiromasa ^b  

^a KITASATO INSTITUTE HOSPITAL   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Culture supernatant; Hepatic stellate cell; Interleukin 6; Liver cirrhosis

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 6;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CHRONIC ACTIVE HEPATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEPATITIS C; HUMAN; HUMAN CELL; ITO CELL; LIVER CELL CULTURE; LIVER CIRRHOSIS; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SUPERNATANT;

EID: 0034034594     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050333     Document Type: Article

References (34)

1. Khoruts A, Stahnke L, McClain CJ, et al. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991;13:267-76.
2. Hill DB, Marsono L, Cohen D, et al. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 1992;119:547-52.
3. Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-74.
4. Miller C, Zielinski CC. Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and patients with acute viral hepatitis. J Hepatol 1992;15:372-7.
5. Anastassakos C, Alexander GJ, Wolstencraft RA, et al. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 1988;94:999-1005.
6. Yoshioka K, Kakumu S, Arao M, et al. Tumor necrosis factor α production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1989;10:769-73.
7. Deviere J, Conteent J, Denys C. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990;11:628-34.
8. Sakamoto S, Koga S, Ibayashi H. Interleukin-1 activity in culture supernatant of lipopolysaccharide-stimulated monocytes from patients with chronic liver disease. Hepatogastroenterology 1984; 31:248-53.
9. Friedman SL, Roll FJ. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with stractan. Anal Biochem 1987;161:207-18.
10. Davis BH, Pratt BM, Madri JA. Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding protein levels. J Biol Chem 1987;262: 10280-6.
11. Chen W, Gendrault JL, Steffan AM, et al. Isolation, culture and main characteristics of mouse fat-storing cells: interaction with viruses. Hepalology 1989;9:352-62.
12. Yokoi Y, Namihisa T, Kuroda T, et al. Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology 1984;4:709-14.
13. Takase S, Leo MA, Nouchi T, et al. Desmin distinguishes cultured fat-storing cells from myofibroblasts, smooth muscle cells and fibroblasts in the rat. J Hepatol 1998;6:267-76.
14. Strong DM, Ahmed AA, Thurman GB, et al. In vitro stimulation of murine spleen cells using a microculture system and a multiple automated sample harvester. J Immunol Methods 2 1973: 279.
15. Milani S, Herbst H, Schuppan D, et al. Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. Gastroenterology 1990;98:175-84.
16. Milani S, Herbst H, Schuppan D, et al. In situ hybridization for procollagen types I,III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. Hepatology 1989;10:84-92.
17. Nakatsukasa H, Nagy P, Evarts RP, et al. Cellular distribution of transforming growth factor-β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990;85:1833-43.
18. Bachem MG, Riess U, Gressner AM. Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor β. Biochem Biophys Res Commun 1989;162:708-14.
19. French SW, Miyamoto K, Wong K, et al. Role of the Ito cell in liver parenchymal fibrosis in rats fed alcohol and a high fat-low protein diet. Am J Pathol 1988;132:73-85.
20. Mayer DH, Bachem MG, Gressner AM. Modulation of hepatic lipocyte proteoglycan synthesis; and proliferation by Kupffer cell-derived transforming growth factors type β1 and type α. Biochem Biophys Res Commun 1990;171:1122-9.
21. Lasfargues A, Chaby R. Endotoxin-induced tumor necrosis factor (TNF): selective triggering of TNF and IL-I production by glucosamine-derived lipids. Cell Immunol 1988;115:165-78.
22. Kumagai N, Tsuchimoto K, Toda K, Takeuchi O, Saito H, et al. Association of production of interleukin-1-β in chronic hepatitis C virus infection with presence of hepatitis C virus RNA in peripheral blood mononuclear cells. Hepatol Res 1990;8:121-9.
23. Win KM, Charlotte F, Mallat A, et al. Mitogenic effect of transforming growth factor β1 on humen Ito cells in culture: evidence for madiation by endogenous platelet-derived growth factor. Hepatology 1993;18:137-45.
24. Blazejewski S, Preaux AM, Mallat A, et al. Human myofibroblast-like cells obtained by outgrowth are representative of the fibrogenic cells in the liver. Hepatology 1995;22:788-96.
25. Pinzani M, Gesualdo L, Sabbah GM, et al. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989;84:1786-93.
26. Diviere J, Content J, Denys C, et al. High interleukin-6 serum levels and increased production by leukocytes in alcoholic liver cirrhosis. Correlation with Ig A serum levels and lymphokine production. Clin Exp Immunol 1989;77:221-5.
27. Kakuma S, Shinagawa T, Ishikawa T, et al. Interleukin-6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis. Gastroenterol Jpn 1993;28:18-24.
28. Kakuma S, Shinagawa T, Ishikawa T, et al. Serum interleukin-6 levels in patients with chronic hepatitis B. Am J Gastroenterol 1991;86:1804-8.
29. Sun Y, Tokushige K, Isono E, et al. Elevated serum interleukin-6 levels in patients with acute hepatitis. J Clin Immunol 1992;12: 192-200.
30. Lee FY, Lu RH, Tsai YT, et al. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-α, and hyperdynamic circulation. Scand J Gastroenterol 1996;31:500-5.
31. Choi I, Rang HS, Yang Y, et al. IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clin Exp Immunol 1994;95: 530-5.
32. Tiggelman Anke MBC, Boers W, Linthorst C, et al. Interleukin-6 production by human liver (myo) fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1β and TNF-α. J Hepatol 1995;23:295-306.
33. Austrian R, Gold J. Pneumococcal pneumonia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964;60:759-76.
34. Conn HO, Fessel JM. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine (Baltimore) 1971;50:161-97.